Updates in Management of Bone Metastatic Disease in Primary Solid Tumors with Systemic Therapies
Last Updated: Wednesday, December 8, 2021
Focusing on data from the past five years, this review article takes a deep dive into systemic treatment for solid tumor bone metastasis, specifically decreasing dosing frequency of zoledronic acid in metastatic breast and prostate cancer and the use of radium-223 to treat metastatic prostate cancer.
Advertisement
News & Literature Highlights